Radiopharm Theranostics (RADX) Accumulated Expenses (2024 - 2025)
Radiopharm Theranostics (RADX) recorded Accumulated Expenses of $1.76 million in fiscal Q4 2025 (quarter ended Jun 30, 2025), up 59.1% from $1.11 million a year earlier.
Powered by 
Analysis
Radiopharm Theranostics (RADX) Accumulated Expenses (2024 - 2025) Analysis & Trends
- Across earlier fiscal years, Accumulated Expenses came in at $1.11 million in FY2024.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn |
| 10 | Radiopharm Theranostics | 5.74 Bn | 5.70 Bn | 186,835.86 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2025 | 1.76 Mn |
| Dec 31, 2024 | 4.18 Mn |
| Jun 30, 2024 | 1.11 Mn |
API Access
Radiopharm Theranostics Accumulated Expenses API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=accumulated-expenses&ticker=RADX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "accumulated-expenses", "ticker": "RADX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=accumulated-expenses&ticker=RADX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();